U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
LUTIKIZUMAB
INN   WHO-DD  
USAN   INN  
Official Name English
LUTIKIZUMAB [USAN]
Common Name English
ABT-981
Code English
Lutikizumab [WHO-DD]
Common Name English
Immunoglobulin G1-kappa, anti-[Homo sapiens IL1A (interleukin 1 alpha) and Homo sapiens IL1B (interleukin 1 beta, IL-1B, 1L1F2)], humanized monoclonal antibody, tetravalent bispecific; gamma1 heavy chain (1-577) [humanized VH anti-IL1B (Homo sapiens IGHV
Common Name English
lutikizumab [INN]
Common Name English
A-1234138
Code English
Immunoglobulin, anti-(interleukin 1β/interleukin 1α) (synthetic human A-1234138 heavy chain), disulfide with synthetic human A-1234138 light chain, dimer
Common Name English
Code System Code Type Description
USAN
JK-209
Created by admin on Sat Dec 16 11:55:24 UTC 2023 , Edited by admin on Sat Dec 16 11:55:24 UTC 2023
PRIMARY
FDA UNII
15FAZ725S0
Created by admin on Sat Dec 16 11:55:24 UTC 2023 , Edited by admin on Sat Dec 16 11:55:24 UTC 2023
PRIMARY
INN
10347
Created by admin on Sat Dec 16 11:55:24 UTC 2023 , Edited by admin on Sat Dec 16 11:55:24 UTC 2023
PRIMARY
CAS
1791411-57-8
Created by admin on Sat Dec 16 11:55:24 UTC 2023 , Edited by admin on Sat Dec 16 11:55:24 UTC 2023
PRIMARY
NCI_THESAURUS
C166465
Created by admin on Sat Dec 16 11:55:24 UTC 2023 , Edited by admin on Sat Dec 16 11:55:24 UTC 2023
PRIMARY
ACTIVE MOIETY
LUTIKIZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966